Magnificent Seven: opportunities arise from divergent performance
With economic factors such as inflation and central bank actions looming large, the outlook for technology stocks remains uncertain.
The contract went through 10 iterations between July 2019 and March 2020, with the term ‘infectious and contagious diseases’ variously in or out.
Read moreWith economic factors such as inflation and central bank actions looming large, the outlook for technology stocks remains uncertain.
The long, painfully slow post-bubble recovery of the Japanese market forces us to ask whether there is a similar risk to the euphoria over AI.